CONMED Corp. buy Piper Sandler
Start price
27.10.23
/
50%
€89.00
Target price
27.10.24
€123.12
Performance (%)
-34.83%
End price
28.10.24
€58.00
Summary
This prediction ended on 28.10.24 with a price of €58.00. The BUY prediction by Piper_Sandler for CONMED Corp. performed very badly with a performance of -34.83%. Piper_Sandler has a follow-up prediction for CONMED Corp. where he still thinks CONMED Corp. is a Buy. Dividends of €0.73 are taken into consideration when calculating the performance. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CONMED Corp. | 3.247% | 3.247% | -43.214% |
| iShares Core DAX® | -0.479% | -12.062% | -2.949% |
| iShares Nasdaq 100 | -3.377% | -5.130% | 9.585% |
| iShares Nikkei 225® | -0.143% | -12.633% | 20.316% |
| iShares S&P 500 | -2.266% | -5.049% | 5.803% |
Comments by Piper_Sandler for this prediction
In the thread CONMED Corp. diskutieren
CONMED Co. (NYSE: CNMD) had its price target lowered by analysts at Piper Sandler from $145.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for CNMD provided by MarketBeat
In the thread Trading CONMED Corp.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten